TMCI
Treace Medical Concepts Inc

337
Mkt Cap
$182.23M
Volume
543,831.00
52W High
$10.79
52W Low
$2.56
PE Ratio
-3.66
TMCI Fundamentals
Price
$2.91
Prev Close
$2.86
Open
$2.88
50D MA
$4.77
Beta
1.18
Avg. Volume
1.26M
EPS (Annual)
-$0.8975
P/B
2.08
Rev/Employee
$438,903.56
Loading...
Loading...
News
all
press releases
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives Consensus Rating of "Reduce" from Brokerages
Treace Medical Concepts, Inc. (NASDAQ:TMCI - Get Free Report) has earned an average rating of "Reduce" from the seven analysts that are presently covering the company, MarketBeat.com reports. Two...
MarketBeat·8d ago
News Placeholder
More News
News Placeholder
CenterBook Partners LP Purchases Shares of 562,710 Treace Medical Concepts, Inc. $TMCI
CenterBook Partners LP acquired a new stake in shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI - Free Report) during the 2nd quarter, according to the company in its most recent filing with the...
MarketBeat·18d ago
News Placeholder
Truist Financial Reaffirms "Hold" Rating for Treace Medical Concepts (NASDAQ:TMCI)
Truist Financial reaffirmed a "hold" rating and set a $4.00 price objective (down previously from $7.00) on shares of Treace Medical Concepts in a research note on Monday...
MarketBeat·1mo ago
News Placeholder
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Given Consensus Rating of "Reduce" by Brokerages
Shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI - Get Free Report) have been given a consensus rating of "Reduce" by the seven analysts that are currently covering the stock, MarketBeat.com...
MarketBeat·1mo ago
News Placeholder
UBS Group Cuts Treace Medical Concepts (NASDAQ:TMCI) Price Target to $5.85
UBS Group dropped their price target on shares of Treace Medical Concepts from $6.50 to $5.85 and set a "neutral" rating on the stock in a research report on Friday...
MarketBeat·1mo ago
News Placeholder
Treace Medical Concepts (NASDAQ:TMCI) Receives "Underweight" Rating from JPMorgan Chase & Co.
JPMorgan Chase & Co. reissued an "underweight" rating and set a $5.00 target price (down previously from $8.00) on shares of Treace Medical Concepts in a report on Friday...
MarketBeat·1mo ago
News Placeholder
Treace Medical Concepts (NASDAQ:TMCI) Receives Neutral Rating from BTIG Research
BTIG Research reaffirmed a "neutral" rating on shares of Treace Medical Concepts in a report on Friday...
MarketBeat·1mo ago
News Placeholder
Treace Medical Concepts (NASDAQ:TMCI) Lowered to Sell Rating by Wall Street Zen
Wall Street Zen cut Treace Medical Concepts from a "hold" rating to a "sell" rating in a research report on Saturday...
MarketBeat·1mo ago
News Placeholder
Treace Medical Concepts (NASDAQ:TMCI) Releases Earnings Results, Beats Estimates By $0.02 EPS
Treace Medical Concepts (NASDAQ:TMCI - Get Free Report) announced its quarterly earnings results on Thursday. The company reported ($0.26) EPS for the quarter, beating analysts' consensus estimates...
MarketBeat·1mo ago
News Placeholder
Treace Medical Concepts (TMCI) Reports Q3 Loss, Beats Revenue Estimates
Treace Medical Concepts (TMCI) delivered earnings and revenue surprises of +7.14% and +1.27%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago

Latest TMCI News

View

Advertisement|Remove ads.

Advertisement|Remove ads.